Previous Close | 36.31 |
Open | 36.08 |
Bid | 38.08 x 1200 |
Ask | 38.17 x 1800 |
Day's Range | 33.02 - 36.96 |
52 Week Range | 14.62 - 43.81 |
Volume | |
Avg. Volume | 413,386 |
Market Cap | 891.701M |
Beta (5Y Monthly) | 2.64 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.12 |
Earnings Date | May 07, 2024 - May 13, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 67.63 |
Arcturus Therapeutics Holdings ( NASDAQ:ARCT ) Full Year 2023 Results Key Financial Results Revenue: US$166.8m (down...
In this article, we discuss 12 most undervalued biotech stocks to buy according to hedge funds. If you want to skip our discussion on the biotech industry, head over to 5 Most Undervalued Biotech Stocks To Buy According To Hedge Funds. Fitch Ratings maintains a Neutral outlook for the global pharmaceutical and biotech industry in […]
Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Q4 2023 Earnings Call Transcript March 7, 2024 Arcturus Therapeutics Holdings Inc. beats earnings expectations. Reported EPS is $-0.32, expectations were $-1.69. ARCT isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings and welcome to […]